期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

瑞舒伐他汀对原发性高胆固醇血症患者高敏C反应蛋白和红细胞分布宽度的影响 被引量：2

The Effect of Rosuvastatin on Serum High Sensitive C-reactive Protein and Red Blood Cell Distribution Width in Patients with Hypercholesterolemia
下载PDF
导出
摘要 目的探讨原发性高胆固醇血症患者高敏C反应蛋白(hs-CRP)和红细胞分布宽度(RDW)的关系及瑞舒伐他汀对其的影响。方法分别采用免疫比浊法和全自动血细胞分析仪测定136例高脂血症患者的血清hs-CRP和RDW,并与80例正常人进行对照。原发性高胆固醇血症患者口服瑞舒伐他汀10 mg,1次/日。在治疗1个月、3个月和6个月后复查血脂、hs-CRP和RDW。结果原发性高胆固醇血症患者血清hs-CRP含量显著高于正常对照组,RDW也明显高于正常对照组。瑞舒伐他汀治疗1个月后,血清hs-CRP浓度显著降低,治疗3个月后RDW也显著降低。结论原发性高胆固醇血症患者血清hs-CRP浓度和RDW均升高,采用瑞舒伐他汀治疗显著降低了hs-CRP,同时也显著降低了RDW。 OBJECTIVE To investigate the relationship between serum high sensitive C-reactive protein（hs-CRP） and red blood cell distribution width（RDW） in patients with hypercholesterolemia and the effect of rosuvastatin on hs-CRP and RDW. METHOD hs-CRP and RDW were measured in 136 patients with hypercholesterolemia and in 80 healthy subjects by chemical method and automatic blood cell analyzer respectively in 1.3 and 6 months after oral treatment with 10mg rosuvastatin, once per day, the lipid level, hs-CRP and RDW were remeasured. RESULT The hs-RCP level in patients with hypercholesterolemia was significantly higher than that of normal control and RDW was also significantly higher than that of normal control. The hs-CRP concentration was significantly decreased after 1 month of treatment and the RDW was also significantly decreased after 3 months of treatment with rosuvastatin. CONCLUTION Both hs-CRP and RDW were higher in patients with hypercholesterolemia than that in healthy subjects, rosuvastatin significantly decreased hs-CRP and also reduced RDW.
作者 白玉云 魏玮 赵子霞 李晨刚
机构地区 嘉峪关市酒钢医院
出处 《中国初级卫生保健》 2014年第11期106-107,共2页 Chinese Primary Health Care
关键词 高胆固醇血症 红细胞分布宽度 高敏C-蛋白反应 瑞舒伐他汀 hypercholesterolemia red blood cell distribution width hs-C-reactive protein Rosuvastatin
分类号 R589.3 [医药卫生—内分泌]
  • 相关文献

参考文献8

  • 1Rosenfeld M E,Inflammation and atherosclerosis:direct versus indirect mechanism[J].Curr Opin Pharmacol,2013,13(1):154-160.
  • 2Shah T,Casas J P,Cooper J A,et al.Critical appraisal of CRP measurement for the prediction of coronary heart disease events:new data and systematic review of 31 prospective cohorts[J].Int J Epidemiol,2009,389(2):217-231.
  • 3Buckley D I,Fu R,Freeman M,et al.C-reactive protein as a risk factor for coronary heart disease:a systematic review and meta-analyses for the U.S.Preventive Services Task Force[J].Ann Inter Med,2009,151(4):483-495.
  • 4Zalawadiya S K,Veeranna V,Niraj A,et al.Red cell distribution width and risk of coronary heart disease events[J].Am J Cardiol,2010,106(7):988-993.
  • 5Chen P C,Sung F C,Chien K L,et al.Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan[J].Am J Epidemiol,2010,171(2):214-220.
  • 6Lippi G,Targher G,Montagnana M,et al.Relation between red blood cell distribution width and inflammatory biomarker in a large cohort of unselected outpatients[J].Arch Pathol Lab Med,2009,133(4):628-632.
  • 7Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量：117
  • 8Mora S,Glynn R J,Hsia J,et al.Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia:results from the Justification for the Use of Statins in Prevention:An Intervention Trim Evaluating Rosuvastatin(JUPITER) and meta-analysis of women from primary prevention trials[J].Circulation,2010,121(9):1069-1077.

二级参考文献2

共引文献116

同被引文献37

  • 1何磊,魏庆民.红细胞分布宽度的临床应用新进展[J].医学综述,2013,19(1):135-137.
  • 2Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution with as a novelprognostic marker in heart failure : data from the CHARM Program and the Dukedatabank[ J]. J Am Coll Cardiol,2007,50(1) :40-47.
  • 3Zhang M,Zhang Y,Li C, et al. Association between red blood cell distributionand renal function in patients with untreated type 2 diabetes mellitus [ J ]. RenFail,2015,37(4) :659-663.
  • 4Akin F, Kose N, Ayga B,et al. Relation between red cell distribution widthand severity of coronary artery disease in patients with acute myocardial infarc-tion[ J]. Angiology,2013,64(8) :592-596.
  • 5Osadnik T, Strzelczyk J, Bujak K,et al. Functional polymorphism rs710218 inthe gene coding GLUT1 protein is associated with in-stent restenosis [ J] . Bio-mark Med, 2015,9(8) :743-750.
  • 6Tonelli M, Sacks F, Arnold M,et al. Relation between red blood cell distribu-tion width and cardiovascular event rate in people with coronary disease [ J].Circulation, 2008,117(2):163-168.
  • 7Sangoi MB,Guarda Ndos S, Rodel AP,et al. Prognostic value of red blood celldistribution width in prediction of in_hospital mortality in patients with acute my-ocardial infarction[J]. Clin Lab,2014,60(8) :1351-1356.
  • 8Lippi G, Filippqzzi L, Montagnana M, et al. Clinical usefulness of measuringred blood cell distribution width on admission in patients with acute coronarysyndromes[ J]. Clin Chem Lab Med,2009,47(3) :353-357.
  • 9Wen Y. High red blood cell distribution width is closely associated with risk ofcarotid artery atherosclerosis in patients with hypertension [ J ] . Exp Clin Cardiol,2010,15(3):37^0.
  • 10Ye Z,Smith C,Kullo IJ. Usefulness of red cell distribution width to predict mor-tality in patients with peripheral artery disease [ J]. Am J Cardiol, 2011, 107(8) : 1241-1245.

引证文献2

二级引证文献12

中国初级卫生保健
2014年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部